Európska únia - slovenčina - EMA (European Medicines Agency)

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - Ďalšie lieky na nervový systém - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zentiva k.s., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zentiva k.s., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zentiva k.s., Česká republika - salmeterol a flutikazón - 14 - bronchodilatantia, antiasthmatica

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

hameln pharma gmbh, nemecko - dobutamín - 41 - cardiaca

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

hameln pharma gmbh, nemecko - dobutamín - 41 - cardiaca

Európska únia - slovenčina - EMA (European Medicines Agency)

accord healthcare s.l.u. - icatibant acetate - angioedémy, dedičné - other hematological agents - icatibant accord is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 esterase inhibitor deficiency.

Slovensko - slovenčina - myHealthbox

bayer ag - tekutý koncentrát miešateľný s vodou - ethephon 480 g/l

Európska únia - slovenčina - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - viacnásobný myelóm - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Slovensko - slovenčina - myHealthbox

bayer ag - tekutý koncentrát miešateľný s vodou - ethephon 480 g/l